News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche’s TROP2 diagnostic assay
Raffaele Colombo/LinkedIn
May 4, 2025, 03:18

Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche’s TROP2 diagnostic assay

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X by Stephen V Liu, adding:

“Based on AstraZeneca’s QCS for TROP2,
Roche Diagnostics received FDA Breakthrough Device Designation (BDD) for the VENTANA TROP2 (EPR20043) RxDx assay!
Nice spotlight presentation at AACR25.”

Read more about Roche’s FDA Breakthrough Device Designation for AI-driven NSCLC diagnostic here.

Raffaele Colombo

Quoting Stephen V Liu‘s post:

“Dr. Marina Garassino at WCLC24 Presidential Plenary presents Normalized Membrane Ratio of TROP2 as a biomarker for datopotamab deruxtecan in TROPION-Lung01 (Dato-DXd vs docetaxel in previously treated NSCLC which previously showed PFS benefit with Dato-DXd.“

Stephen V Liu

Learn more about Raffaele Colombo and TROPION-Lung01 on OncoDaily. 

AACR AACR25 AstraZeneca Breakthrough Device Designation cancer Dato-DXd datopotamab deruxtecan FDA Marina Garassino Medicine at Georgetown University NSCLC OncoDaily Oncology Roche Diagnostics Stephen V Liu TROP2 TROPION-Lung01 VENTANA TROP2 WCLC24 Zymeworks
Special Coverage
Blog
Jun 8, 2025, 10:14
Narjust Florez: An Amazing Mentee that is Part of the Florez Lab
Blog
Jun 8, 2025, 10:10
Society for Integrative Oncology Highlights Research Survey Led by Kristina Gowin
Blog
Jun 8, 2025, 10:03
Ola Khorshid: A landmark step toward transforming Cancer Care, Research, and Education in Egypt and the MENA region
Blog
Jun 8, 2025, 10:02
Reviewing the Highlights of ASCO 2025 - Tres Uramigas
Blog
Jun 8, 2025, 09:59
Key Achievements Highlighted at EU-CAYAS-NET Ambassador Event in Vienna - SIOP Europe
Blog
Jun 8, 2025, 09:53
Martin Zapata Laguado: The First Symposium on CNS Primary Disease
Blog
Jun 8, 2025, 09:53
Janette Merrill: Bookending ASCO AM with the Rural Oncology Conference
Blog
Jun 8, 2025, 09:42
Haryana Dhillon: Talking About the Results of the CHALLENGE Trial on ABC Health Report
Science
Jun 8, 2025, 09:31
Goutham Sunny: Colorectal Cancer Screening - Evolving Landscape
Science
Jun 8, 2025, 09:15
Myeloma Paper of the Day, June 8th, suggested by Robert Orlowski
Blog
Jun 8, 2025, 09:08
Joanna Metzner-Sadurski: Day 1 at the Rural Oncology Conference with Co-founders of the Rural Oncology Institute
Blog
Jun 8, 2025, 09:03
Jason Mouabbi and Paolo Tarantino Discuss How T-DXd + Pertuzumab Could Reshape Frontline Treatment in HER2+ mBC